Natalie Bergstrom’s work with ATMA includes working closely with a team in developing and facilitating course offerings with a view to equip students through both didactic and experiential opportunities to become effective psychedelic-assisted therapy facilitators.  She also oversaw the Palliative Care Program at ATMA that worked with over 20 people to receive Psychedelic-Assisted Therapy for end of life distress through Section 56 Exemptions and SAPs starting in 2020.
Natalie’s passion for education and nurturing listeners and learners has been a lifelong pursuit, beginning with a private teaching practice after attaining her degree in classical music.  She enjoyed roles as an on-air radio personality, years as an on-air television journalist producing and directing a weekly magazine-style show focusing on humanitarian stories, as well as contributing to a daily live program for a national television station. In addition to these public roles, she managed multiple television station locations, designed and oversaw studio expansions, and has managed a promotional program for artists and musicians with an international humanitarian organization. Bringing these skills and experiences into the realm of psychedelic-assisted therapy, beginning in underground intentional work, intensive learning, and sitting for hundreds of personal journeys, and making the shift to working with ATMA working with Health Canada to open the doors for Canadians to access these medicines legally through training and trials continues to be a challenging and rewarding experience.

Dr. Erika Dyck is a Professor at the University of Saskatchewan, and a Canada Research Chair in the History of Medicine. She is the author of Psychedelic Psychiatry: LSD from Clinic to Campus (Johns Hopkins, 2008; University of Manitoba Press, 2011), Managing Madness: The Weyburn Mental Hospital and Transformations of Psychiatric Care in Canada (2017) and the co-editor of Culture’s Catalyst: Encounters with Peyote and the Native American Church in Canada (2016) and Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond (2018).

Bruce Sanguin has been a Clinical Fellow with the Canadian Association of Marriage and Family Therapists for 25 years. He currently lives in Victoria, BC where he practices as a psychotherapist. He is the author of seven books, the latest of which, Dismantled: How Love and Psychedelics Broke a Clergyman Apart and Put Him Back Together, describes his own healing journey using psychedelics in the context of psychedelic-assisted psychotherapy. As well as practicing psychotherapy, Bruce is a keynote speaker at psychedelic conferences, with an active interest in the integration of spirituality and psychology.

Dr. Saundra Jain is an Adjunct Clinical Affiliate, School of Nursing, at The University of Texas at Austin, and a psychotherapist in private practice. Dr. Jain is a co-creator of the WILD 5 Wellness Program and co-author of a well-received workbook written for those interested in improving their mental wellness – KickStart30: A Proven 30-Day Mental Wellness Program. She is co-creator of the Psychedelics and Wellness Survey (PAWS) exploring the intersect between psychedelics and wellness. She serves as a member of the Psych Congress Steering Committee providing direction regarding educational gaps/needs for mental health practitioners, and Sana Symposium providing psychedelics education for mental health and addiction professionals.

Mike is an addiction and trauma therapist with 15 years of experience working in residential and outpatient treatment programs with both individuals and groups. His therapeutic ethos focuses on offering the development of evidence-based skills as well as support to integrate these skills so that his clients may realize a more fulfilling life. He practices a blend of approaches including motivational interviewing, acceptance and commitment therapy (ACT) and existential therapy. Mike believes in the transformative power of psychedelic medicines to connect people with their inner healing intelligence and the embodied wisdom accessible to all. He recognizes the importance of a safe container being created (including preparation and integration), and values how this supports the development of psychological flexibility, potentially leading to profound and lasting improvements in the person’s quality of life via behavioural change. Mike has been working with first responders for the past 2 years facilitating PTSD healing groups. His recent efforts have been focused on the development of Resilient Living Recovery (RLR), a 10 week online addiction treatment program for people with mild to moderate substance use problems. Since 2018, Mike has presented at the Spirit Plant Medicine Conference and has been training as a study therapist for clinical research led by the Multidisciplinary Association for Psychedelic Studies (MAPS) on a clinical trial that will see the MAPS MDMA protocol for trauma applied to eating disorders. He has also been approved as a research therapist on a clinical trial with Numinous that will investigate the use of psilocybin for substance use disorders via motivational enhancement therapy. Mike has attended several psychedelic integration workshops and is a consultant for PsyGen Labs focusing on the therapeutic aspects pertaining to the development of psychedelic medicine clinical trials.

Trevor Millar is a social-entrepreneur with over a decade of experience providing ibogaine therapy. He is a co-founder of Ambio Life Sciences Inc. and is responsible for various aspects of Ambio’s operations and communications. He previously served as a board member and co-founder of the Canadian Psychedelic Association and from 2018 to 2021 was on the board of directors for the Multidisciplinary Association of Psychedelic Studies (MAPS) Canada, where he acted as Chair of the Board for over two years. Trevor was featured in the award-winning documentary about using magic mushrooms and Iboga to treat addiction, anxiety and depression called DOSED, which was released in 2019.

Dr. Anthony Bossis is a clinical psychologist and Clinical Assistant Professor of Psychiatry at New York University School of Medicine. He is Director of Palliative Care Research, Co-Principal Investigator, and a session guide for the NYU Psilocybin Cancer Anxiety Project, a FDA-approved clinical trial investigating the efficacy of a psilocybin-generated mystical experience upon existential and psycho-spiritual distress in persons with cancer.

Dr. Christie is a clinical instructor with the UBC Department of Medicine and a family physician with a focused practice in Multidisciplinary Pain Management. She is a Registered Therapeutic Counsellor emphasizing Relational Somatic Therapy for trauma resolution and is trained to deliver both MDMA-assisted psychotherapy for PTSD (MAPS USA) and ketamine-assisted psychotherapy, in a research setting. She is a recognized speaker and expert on the potential for incorporating psychedelic assisted therapies in an improved health care model for the future.

Taunya, is a seasoned Counsellor with over a decade of experience in private practice. As a Registered Professional Counsellor (RPC), Master Practitioner in Clinical Counselling (MPCC), and Counselling Therapist (CT), her commitment to providing cutting-edge therapeutic interventions led her to become a certified Master A.R.T. Practitioner, an IFS informed therapist, and a polyvagal informed treatment therapist, and accumulating over 350 hours of specialized psychedelic-assisted psychotherapy training.

With a diverse background that spans hundreds of hours in facilitating group work, thousands of direct client hours, and spearheading the design and implementation of Bloom Psychedelic Therapy and Research Institute’s Ketamine program, she is passionate about pushing the boundaries of mental health care. Her journey has been marked by a dedication to fostering a safe and transformative space for individuals seeking alternative therapies.

Mark Haden is an Adjunct professor at the University of British Columbia, School of Population and Public Health. As the past Executive Director of MAPS Canada (Multidisciplinary Association for Psychedelic Studies), he has published on the issue of drug control policy and psychedelics in the following Journals: Canadian Journal of Public Health, International Journal of Drug Policy, Encyclopaedia of Public Health, Harm Reduction Journal, Open Medicine, Journal of Psychoactive Drugs, and the Journal of Studies on Alcohol and Drugs. Mark teaches in the UBC school of medicine (Population and Public Health), obtained an MSW from UBC and worked for the Addiction Services for 28 years in counselling and supervisory roles. He has provided public education on drugs and drug policy for over 30 years and works with the Health Officers Council of British Columbia on their position papers on the issue of a regulated market for all currently illegal drugs. He has presented in conferences and training events in many countries and was awarded the Queen’s Diamond Jubilee Medal for drug policy reform work in 2013.